Liang Y - Search Results

1

The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial.

Hernandez J, Gelfond J, Goros M, Liss MA, Liang Y, Ankerst D, Thompson IM Jr, Leach RJ. Hernandez J, et al. Among authors: liang y. PLoS One. 2018 Oct 9;13(10):e0204823. doi: 10.1371/journal.pone.0204823. eCollection 2018. PLoS One. 2018. PMID: 30300367 Free PMC article. Clinical Trial.

2

Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.

Liang Y, Ankerst DP, Sanchez M, Leach RJ, Thompson IM. Liang Y, et al. Urology. 2010 Nov;76(5):1268.e1-6. doi: 10.1016/j.urology.2010.04.060. Epub 2010 Aug 24. Urology. 2010. PMID: 20739049 Free PMC article.

3

Prospective evaluation of operating characteristics of prostate cancer detection biomarkers.

Liang Y, Ankerst DP, Ketchum NS, Ercole B, Shah G, Shaughnessy JD Jr, Leach RJ, Thompson IM. Liang Y, et al. J Urol. 2011 Jan;185(1):104-10. doi: 10.1016/j.juro.2010.08.088. Epub 2010 Nov 12. J Urol. 2011. PMID: 21074193 Free PMC article. Clinical Trial.

4

Trends and co-trends of prostate-specific antigen and body mass index in a screened population.

Ankerst DP, Pollock BH, Liang Y, Dizdarevic N, Kyrylenko S, Boeck A, Thompson IM, Leach R. Ankerst DP, et al. Among authors: liang y. Urology. 2011 Jul;78(1):10-6. doi: 10.1016/j.urology.2011.01.069. Epub 2011 May 7. Urology. 2011. PMID: 21550639 Free PMC article.

5

Updating risk prediction tools: a case study in prostate cancer.

Ankerst DP, Koniarski T, Liang Y, Leach RJ, Feng Z, Sanda MG, Partin AW, Chan DW, Kagan J, Sokoll L, Wei JT, Thompson IM. Ankerst DP, et al. Among authors: liang y. Biom J. 2012 Jan;54(1):127-42. doi: 10.1002/bimj.201100062. Epub 2011 Nov 17. Biom J. 2012. PMID: 22095849 Free PMC article.

6

Prostate cancer risk prediction in a urology clinic in Mexico.

Liang Y, Messer JC, Louden C, Jimenez-Rios MA, Thompson IM, Camarena-Reynoso HR. Liang Y, et al. Urol Oncol. 2013 Oct;31(7):1085-92. doi: 10.1016/j.urolonc.2011.12.023. Epub 2012 Feb 3. Urol Oncol. 2013. PMID: 22306115 Free PMC article.

7

The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community setting.

Liang Y, Ankerst DP, Feng Z, Fu R, Stanford JL, Thompson IM. Liang Y, et al. Urol Oncol. 2013 Nov;31(8):1464-9. doi: 10.1016/j.urolonc.2012.03.012. Epub 2012 May 1. Urol Oncol. 2013. PMID: 22552047 Free PMC article.

8

The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.

Liang Y, Ketchum NS, Louden C, Jimenez-Rios MA, Thompson IM, Camarena-Reynoso HR. Liang Y, et al. Urol Int. 2012;89(1):9-16. doi: 10.1159/000338270. Epub 2012 May 24. Urol Int. 2012. PMID: 22626812

9

Limited PSA testing in indigent men in South Texas: an appropriate care or missing a prevention opportunity?

Liang Y, Du F, Thompson IM, Turner BJ. Liang Y, et al. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1489-96. doi: 10.1158/1055-9965.EPI-12-0497. Epub 2012 Jul 20. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22822113 Free PMC article.

10

Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?

Liang Y, Ketchum NS, Goodman PJ, Klein EA, Thompson IM Jr. Liang Y, et al. J Urol. 2014 Oct;192(4):1094-9. doi: 10.1016/j.juro.2014.04.015. Epub 2014 Apr 18. J Urol. 2014. PMID: 24747090 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,713 results

Search Page

Filters